Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: GlaxoSmithKline, LLC
Current Parent Company: GlaxoSmithKline
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Penalty: $105,000,000
Year: 2014
Date: June 4, 2014
Offense Group: competition-related offenses
Primary Offense: kickbacks and bribery
Secondary Offense: False Claims Act and related
Mega-Scandal: Improper Drug Marketing
Violation Description: GlaxoSmithKline, LLC agreed to pay $105 million to resolve multistate litigation alleging that the company unlawfully promoted its asthma drug, Advair, and antidepressant drugs, Paxil and Wellbutrin.
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: United Kingdom
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Link to Archived Court Document:  subscribe to see this data field
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.